Co-development initiatives to advance next-generation workflows, accelerate adoption, and expand the role of AI within model-informed drug development RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)-- ...
LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus”), a leading provider of biosimulation, simulation-enabled performance and intelligence solutions, and ...
Objective to define best practices for the use of novel PBK modeling strategies to support animal-free safety assessment of new chemicals LANCASTER, Calif.--(BUSINESS WIRE)-- Simulations Plus, Inc.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results